Related references
Note: Only part of the references are listed.Treating ADHD and Comorbid Anxiety in Children: A Guide for Clinical Practice
Roberto Leon-Barriera et al.
CLINICAL PEDIATRICS (2023)
Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders
Maria Flores-Lopez et al.
TRANSLATIONAL PSYCHIATRY (2023)
Investigation of the Relationship among Cortisol, Pro-inflammatory Cytokines, and the Degradation of Tryptophan into Kynurenine in Patients with Major Depression and Suicidal Behavior
Amel Messaoud et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2022)
Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders
Maria Flores-Lopez et al.
BRAIN SCIENCES (2022)
Cocaine Use Disorder (CUD): Current Clinical Perspectives
Elizabeth K. C. Schwartz et al.
SUBSTANCE ABUSE AND REHABILITATION (2022)
The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response
Bashkim Kadriu et al.
MOLECULAR PSYCHIATRY (2021)
Attachment Anxiety Moderates the Association Between ADHD and Psychological Distress
Hadil Kordahji et al.
PSYCHIATRIC QUARTERLY (2021)
The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation
Yuri Milaneschi et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease
Maria Flores-Lopez et al.
BIOMEDICINES (2021)
Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls
Zhaohua Zhang et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2020)
Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients
Nuria Garcia-Marchena et al.
SCIENTIFIC REPORTS (2020)
Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum
Brian De La Franier et al.
BIOSENSORS-BASEL (2020)
Lysophosphatidic acid-induced increase in adult hippocampal neurogenesis facilitates the forgetting of cocaine-contextual memory
David Ladron de Guevara-Miranda et al.
ADDICTION BIOLOGY (2019)
Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide
Amel Messaoud et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2019)
Sex-based differences in multidimensional clinical assessments of early-abstinence crack cocaine users
Breno Sanvicente-Vieira et al.
PLOS ONE (2019)
Effects of the LPA1 Receptor Deficiency and Stress on the Hippocampal LPA Species in Mice
Sara Tabbai et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Does the treatment of anxiety in children with Attention-Deficit/Hyperactivity Disorder (ADHD) using cognitive behavioral therapy improve child and family outcomes? Protocol for a randomized controlled trial
Emma Sciberras et al.
BMC PSYCHIATRY (2019)
Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients
Pedro Araos et al.
SCIENTIFIC REPORTS (2019)
Lipidomic changes in the rat hippocampus following cocaine conditioning, extinction, and reinstatement of drug-seeking
Sumitra Pati et al.
BRAIN AND BEHAVIOR (2019)
Lysophosphatidic acid levels in cerebrospinal fluid and plasma samples in patients with major depressive disorder
Leo Gotoh et al.
HELIYON (2019)
Female crack cocaine users under treatment at therapeutic communities in southern Brazil: characteristics, pattern of consumption, and psychiatric comorbidities
Adriana Raquel Binsfeld Hess et al.
TRENDS IN PSYCHIATRY AND PSYCHOTHERAPY (2019)
Hydrocortisone Affects Fatigue and Physical Functioning Through Metabolism of Tryptophan: A Randomized Controlled Trial
Freek J. H. Sorgdrager et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Synaptic phospholipids as a new target for cortical hyperexcitability and E/I balance in psychiatric disorders
Carine Thalman et al.
MOLECULAR PSYCHIATRY (2018)
Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs
Buranee Kanchanatawan et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Serum lipidomic analysis for the discovery of biomarkers for major depressive disorder in drug-free patients
Eun Young Kim et al.
PSYCHIATRY RESEARCH (2018)
Multi-Target Protective Effects of Gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated Model of Parkinson's Disease via Lysophosphatidic Acid Receptors
Jong Hee Choi et al.
FRONTIERS IN PHARMACOLOGY (2018)
Anxiety Disorders: Sex Differences in Serotonin and Tryptophan Metabolism
Tanya Songtachalert et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Autotaxin is a novel molecular identifier of type I endometrial cancer
Antonio Mazzocca et al.
MEDICAL ONCOLOGY (2018)
Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study
Ken Kuwajima et al.
PLOS ONE (2018)
Sex and gender differences in substance use disorders
R. Kathryn McHugh et al.
CLINICAL PSYCHOLOGY REVIEW (2018)
Lysophosphatidic acid plasma concentrations in healthy subjects: circadian rhythm and associations with demographic, anthropometric and biochemical parameters
Anna Michalczyk et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis
Jelle V. Zorn et al.
PSYCHONEUROENDOCRINOLOGY (2017)
ADHD and Anxiety: Clinical Significance and Treatment Implications
Frederick W. Reimherr et al.
CURRENT PSYCHIATRY REPORTS (2017)
maLPA1-null mice as an endophenotype of anxious depression
R. D. Moreno-Fernandez et al.
TRANSLATIONAL PSYCHIATRY (2017)
Prior alcohol use enhances vulnerability to compulsive cocaine self-administration by promoting degradation of HDAC4 and HDAC5
Edmund A. Griffin et al.
SCIENCE ADVANCES (2017)
Mood symptoms correlate with kynurenine pathway metabolites following sports-related concussion
Rashmi Singh et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Pain and Personality: Do Individuals with Different Forms of Chronic Pain Exhibit a Mutual Personality?
Sylvia M. Gustin et al.
PAIN PRACTICE (2016)
Both genetic deletion and pharmacological blockade of lysophosphatidic acid LPA1 receptor results in increased alcohol consumption
Estela Castilla-Ortega et al.
NEUROPHARMACOLOGY (2016)
Expression of LPA2 is associated with poor prognosis in human breast cancer and regulates HIF-1α expression and breast cancer cell growth
Min Li et al.
ONCOLOGY REPORTS (2016)
G-Protein-Coupled Lysophosphatidic Acid Receptors and Their Regulation of AKT Signaling
Anjum Riaz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study
Tore Ivar Malmei Aarsland et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2015)
Early Life Stress in Depressive Patients: Role of Glucocorticoid and Mineralocorticoid Receptors and of Hypothalamic-Pituitary-Adrenal Axis Activity
Mario Francisco Juruena et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Differential effects of cocaine exposure on the abundance of phospholipid species in rat brain and blood
Brian S. Cummings et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Gintonin, a novel ginseng-derived lysophosphatidic acid receptor ligand, stimulates neurotransmitter release
Sung-Hee Hwang et al.
NEUROSCIENCE LETTERS (2015)
Serum Autotaxin is Independently Associated with Hepatic Steatosis in Women with Severe Obesity
Vikrant P. Rachakonda et al.
OBESITY (2015)
Psychopathological comorbidity in cocaine users in outpatient treatment
Pedro Araos et al.
ADICCIONES (2014)
Fear extinction and acute stress reactivity reveal a role of LPA1 receptor in regulating emotional-like behaviors
C. Pedraza et al.
BRAIN STRUCTURE & FUNCTION (2014)
Sex differences in stress-related psychiatric disorders: Neurobiological perspectives
Debra A. Bangasser et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2014)
Impact of Psychiatric Comorbidity on the In-Treatment Outcomes of Cocaine-Dependent Patients in Therapeutic Communities
Francisco Gonzalez-Saiz et al.
SUBSTANCE ABUSE (2014)
Effects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence
Sharon Samet et al.
ADDICTION (2013)
Relationship between psychopathological comorbidity and outcomes variables in-treatment cocaine dependent subject in therapeutic community
Esperanza Vergara-Moragues et al.
ADICCIONES (2013)
Lysophospholipids and their receptors in the central nervous system
Ji Woong Choi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Lipid Transmitter Signaling as a New Target for Treatment of Cocaine Addiction: New Roles for Acylethanolamides and Lysophosphatidic Acid
Laura Orio et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Lysophosphatidic Acid (LPA) and Its Receptor, LPA1, Influence Embryonic Schwann Cell Migration, Myelination, and Cell-to-Axon Segregation
Brigitte Anliker et al.
GLIA (2013)
Prevalence of Substance Use and Psychiatric Disorders in a Highly Select Chronic Pain Population
Steven L. Proctor et al.
JOURNAL OF ADDICTION MEDICINE (2013)
An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model
Lin Ma et al.
MOLECULAR PAIN (2013)
Anxiety symptoms in crack cocaine and inhalant users admitted to a psychiatric hospital in southern Brazil
Carlos Zubaran et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2013)
Influence of Sex Differences and Gonadal Hormones on Cocaine Addiction
Vanya Quinones-Jenab et al.
ILAR JOURNAL (2012)
Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics
Mary Jeanne Kreek et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Interaction between tryptophan hydroxylase I polymorphisms and childhood abuse is associated with increased risk for borderline personality disorder in adulthood
Scott T. Wilson et al.
PSYCHIATRIC GENETICS (2012)
Psychiatric comorbidity in cocaine users treated in therapeutic community: Substance-induced versus independent disorders
Esperanza Vergara-Moragues et al.
PSYCHIATRY RESEARCH (2012)
An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program
Kevin W. Chen et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
Catalina Lopez-Quintero et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Minireview: Stress-Related Psychiatric Disorders with Low Cortisol Levels: A Metabolic Hypothesis
Rachel Yehuda et al.
ENDOCRINOLOGY (2011)
LPA Receptors: Subtypes and Biological Actions
Ji Woong Choi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls
M. Mercedes Perez-Rodriguez et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Psychiatric comorbidity in young cocaine users: induced versus independent disorders
M. Jesus Herrero et al.
ADDICTION (2008)
Two pathways for lysophosphatidic acid production
Junken Aoki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Gender differences in cocaine dependence
Lisa M. Najavits et al.
DRUG AND ALCOHOL DEPENDENCE (2008)
The molecular neurobiology of depression
Vaishnav Krishnan et al.
NATURE (2008)
Personality profile in young current regular users of cocaine
M. Jesus Herrero et al.
SUBSTANCE USE & MISUSE (2008)
Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity
Shigemi Hosogaya et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2008)
Substance use disorders:: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10)
Deborah Hasin et al.
ADDICTION (2006)
Diagnosing comorbid psychiatric disorders in substance abusers:: Validity of the Spanish versions of the psychiatric research interview for substance and mental disorders and the structured clinical interview for DSM-IV
M Torrens et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Total plasma L-tryptophan, free L-tryptophan and competing amino acid levels in a homicidal male adolescent with conduct disorder
M Virkkunen et al.
ACTA PSYCHIATRICA SCANDINAVICA (2003)
Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood
T Sano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Free L-tryptophan plasma levels in antisocial violent offenders
J Tiihonen et al.
PSYCHOPHARMACOLOGY (2001)
Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: description of procedures
SE Back et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2001)
Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry
DL Baker et al.
ANALYTICAL BIOCHEMISTRY (2001)
Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species - Structure-activity relationship of cloned LPA receptors
K Bandoh et al.
FEBS LETTERS (2000)
Share Paper
